A. David Weaver

A. David Weaver

Auto-generated profile, based on publicly available information

A. David Weaver

Wood Veterinary Group, Gloucester, England

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2024 in Eurosurveillance
Verified
Journal Article
Open access
MSMike Saunders
Mike Saunders
AWAmy Weaver
Amy Weaver
RSRebecca Stretch
Rebecca Stretch
DJD Jeyaratnam
D Jeyaratnam
MMMariyam Mirfenderesky
Mariyam Mirfenderesky
JEJwt Elston
Jwt Elston
We describe an outbreak of Ralstonia pickettii in the United Kingdom, with isolates genetically indistinguishable from a 2023 Australian outbreak linked to internationally distributed saline solutions. Confirmed cases (n = 3) had bacteraemia, clinically relevant infection, indwelling venous lines and frequent healthcare contact. Multi-stakeholder intervention was required including product recall and risk communications. We recommend a low threshold for investigating clusters of Ralstonia species and similar opportunistic pathogens, considering contaminated product sources. Effective mitigation requires multi-agency partnership and international collaboration.

4 September 2025 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Open access
PDF file
JDJason Doran
Jason Doran
CFClare Foster
Clare Foster
MSMike Saunders
Mike Saunders
NCNastassya L Chandra
Nastassya L Chandra
Jane TurtonJane Turton
Jane Turton
JEJ.W.T. Elston
J.W.T. Elston
Background: Species of the Burkholderia (B.) cepacia complex (Bcc) have been implicated in multiple nosocomial outbreaks linked to contaminated water-based products, including liquid soaps, mouthwash, and other non-alcoholic aqueous solutions. Objective: We describe two substantial healthcare-associated outbreaks of Bcc ( B. cepacia and B. contaminans ) in the United Kingdom and Ireland associated with contaminated products. We highlight the challenges during investigation and mitigation, and provide recommendations. Methods: A multidisciplinary, multi-stakeholder investigation across both outbreaks was adopted, involving interviews, trawling questionnaires, and targeted product sampling. Results: There were 153 and 66 confirmed cases in the B. cepacia and B. contaminans outbreaks, respectively. Cases predominantly comprised hospitalized individuals, and 70% of isolates were recovered from an invasive site. The outbreak strain of B. cepacia was isolated from non-sterile ultrasound gel. An analytical study suggested the B. contaminans cluster was also linked to ultrasound gel; however, a disinfectant wipe product was subsequently identified as the source (0–3 single nucleotide polymorphism differences between case and wipe isolates). Outbreak control measures: The affected disinfectant wipes were withdrawn. The ultrasound gel was not recalled but health system procurement was suspended, rapid clinical guidance was produced and a National Patient Safety Alert was issued. Inter-organizational partnership was required to mitigate risks. Conclusion: Identifying the source of outbreaks associated with contaminated products can be challenging, requiring complex multi-stakeholder interventions. We recommend a low threshold for investigation of Bcc clusters, adopting a multidisciplinary approach to investigation and mitigation, implementing interventions focusing on practice, and prompt product removal to protect patients.

1 March 2018
Verified
Book Chapter
Closed access
PDF file
AWA. David Weaver
A. David Weaver
OAOwen Atkinson
Owen Atkinson
GJGuy St. Jean
Guy St. Jean
ASAdrian Steiner
Adrian Steiner

1 January 2003
Verified
Book Chapter
Closed access
RBRoger W Blowey
Roger W Blowey
AWA David Weaver
A David Weaver

1 January 2003
Verified
Book Chapter
Closed access
RBRoger W Blowey
Roger W Blowey
AWA David Weaver
A David Weaver

1 January 2011
Verified
Book Chapter
Closed access
RBRoger W. Blowey
Roger W. Blowey
AWA. David Weaver
A. David Weaver